EMCDDA Home
  • EN
Search

Figure PDU-1. Estimates of the prevalence of problem drug use (rate per 1 000 population aged 15–64), 2006–11 (last study available)

Part (i) Estimates of overall problem drug use

CountryYearMethodLabelLowHighCentral
Related links:
Cyprus2011TPCyprus 2011 TP1.762.532.09
Slovakia2008OTSlovakia 2008 OT2.098.542.68
Greece2011CRGreece 2011 CR2.463.012.72
Poland2009OTPoland 2009 OT2.103.802.90
Croatia**2011MMCroatia** 2011 MM2.704.233.30
Germany*^2010TMGermany*^ 2010 TM3.714.414.06
Sweden2007TPSweden 2007 TP4.90
Austria2011CRAustria 2011 CR5.205.505.30
Czech Rep.2011TMCzech Rep. 2011 TM4.486.545.51
Bulgaria2009CRBulgaria 2009 CR4.428.246.01
Luxembourg2009OTLuxembourg 2009 OT4.637.816.16
France*2011CMFrance* 2011 CM6.78.87.75
Denmark2009CRDenmark 2009 CR8.599.659.12
United Kingdom2004/10CMUnited Kingdom 2004/10 CM9.119.949.38
Latvia2011TMLatvia 2011 TM7.8412.149.49
Italy2009TMItaly 2009 TM9.6810.239.95
Statistical bulletin 2013: http://www.emcdda.europa.eu/stats13/pdufig1a
For more details see http://www.emcdda.europa.eu/stats13/pdu/tables in the Statistical bulletin 2013.
See also ‘General notes for interpreting data’ on the http://www.emcdda.europa.eu/stats13/help
See also http://www.emcdda.europa.eu/html.cfm/index1372EN.html: National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich.

Notes:

The term 'problem drug use' is defined in the methods and notes section of the Statistical bulletin.

Methods of estimation are abbreviated: CR = Capture-recapture; TM = Treatment multiplier; PM = Police multiplier; MI = Multivariate indicator; TP = Truncated Poisson; CM = Combined methods; MM = Mortality multiplier; OT = Other methods.

Target groups may vary slightly between countries owing to different methods and data sources; therefore comparisons should be made with caution.

The symbol indicates a point estimate, a bar indicates an uncertainty interval, which can be either a 95 % confidence interval or an interval based on sensitivity analysis or an interval based on other method

* In the case of France and Germany alternative estimates were provided. For full details see Table PDU-102

^ Central estimate was not available; a midpoint was calculated as a simple average of the Low and High estimate

Sources:

http://www.emcdda.europa.eu/about/partners/reitox-network

AAA BBB CCC
X 2 3 4
1 2 3 4
X 2 3 4
1 2 3 4
X 2 3 4
1 2 3 4

abcfigN

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 29 May 2013